| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-Aminobutyric Acid Receptors Excites Gonadotropin-Releasing Hormone Neurons
Departments of Internal Medicine (R.A.D., S.M.M.) and Cell Biology (S.M.M.) and National Science Foundation Center for Biological Timing (S.M.M.), University of Virginia, Charlottesville, Virginia 22908; and Division of Neuroscience (S.H., S.R.O.), Oregon National Primate Research Center, Beaverton, Oregon 97006
Address all correspondence and requests for reprints to: Suzanne M. Moenter, Ph.D., Associate Professor, Departments of Medicine and Cell Biology, University of Virginia, Jefferson Park Avenue, PO Box 800578, Room 7145 Multistory Building, Charlottesville, Virginia 22908-0578. E-mail: smm4n{at}virginia.edu.
| ABSTRACT |
|---|
|
|
|---|
-Aminobutyric acid (GABA), acting through GABAA receptors (GABAAR), is hypothesized to suppress reproduction by inhibiting GnRH secretion, but GABA actions directly on GnRH neurons are not well established. In green fluorescent protein-identified adult mouse GnRH neurons in brain slices, gramicidin-perforated-patch-clamp experiments revealed the reversal potential (EGABA) for current through GABAARs was depolarized relative to the resting potential. Furthermore, rapid GABA application elicited action potentials in GnRH neurons but not controls. The consequence of GABAAR activation depends on intracellular chloride levels, which are maintained by homeostatic mechanisms. Membrane proteins that typically extrude chloride (KCC-2 cotransporter, CLC-2 channel) were absent from the GT17 immortalized GnRH cell line and GnRH neurons in situ or were not localized to the proper cell compartment for function. In contrast, GT17 cells and some GnRH neurons expressed the chloride-accumulating cotransporter, NKCC-1. Patch-clamp experiments showed that blockade of NKCC hyperpolarized EGABA by lowering intracellular chloride. Regardless of reproductive state, rapid GABA application excited GnRH neurons. In contrast, bath application of the GABAAR agonist muscimol transiently increased then suppressed firing; suppression persisted 415 min. Rapid activation of GABAAR thus excites GnRH neurons whereas prolonged activation reduces excitability, suggesting the physiological consequence of synaptic activation of GABAAR in GnRH neurons is excitation. | INTRODUCTION |
|---|
|
|
|---|
-aminobutyric acid (GABA) plays a primary role in the transsynaptic control of GnRH neurons (1, 2). GABA is the dominant inhibitory neurotransmitter in the hypothalamus (3), GABAergic neurons synapse on GnRH neurons (4), and there are functional GABAA receptors on these cells (5). Although excitatory responses to GABA were reported in embryonic (6) and transformed GnRH neurons (7, 8), this was largely attributed to the immature nature of those cells, and an underlying assumption has been that activation of GABAA receptors on GnRH neurons in adults inhibits these cells as it does in the vast majority of adult neurons (9). GABAA receptors are ligand-gated ion channels permeable primarily to chloride and, to a small extent, bicarbonate (9). The action of GABA at GABAA receptors thus depends on membrane potential and intracellular chloride concentration. The latter is set by developmentally regulated chloride homeostatic mechanisms. In most mature neurons, low intracellular chloride (<10 mM) is maintained by a neuron-specific potassium-coupled chloride cotransporter, KCC-2, which is widely expressed in the adult brain, but present at low levels in the fetal/neonatal brain (10, 11, 12, 13). Under physiological conditions, KCC-2 causes chloride extrusion, resulting in a reversal potential (EGABA) that is near or below the resting potential so that activation of GABAA receptors at the resting potential results in decreased excitability through shunting inhibition, or chloride influx and inhibition via membrane hyperpolarization, respectively (9). The hyperpolarization-activated chloride channel CLC-2 also depletes intracellular chloride (14). In contrast, the sodium-potassium-2-chloride cotransporter (NKCC-1) typically mediates accumulation of intracellular chloride, depolarizing EGABA (15). In most brain regions, NKCC-1 is expressed at higher levels in the fetal/neonatal period than in adulthood (e.g. Ref. 13).
Given the emphasis that many hypotheses have placed on inhibition of GnRH neuron activity by activating GABAA receptors, we examined the direct actions of GABA on GnRH neurons using brain slice electrophysiological techniques, and defined the expression of transporters and channels involved in chloride homeostasis using molecular and immunohistochemical approaches. Our results show that, in marked contrast to the vast majority of central nervous system neurons, GABAA receptor activation depolarizes GnRH neurons beyond threshold regardless of the developmental or reproductive status of the animals. We conclude that synaptic activation of GABAA receptors excites GnRH neurons due to homeostatic mechanisms that maintain elevated intracellular chloride in these cells.
| RESULTS |
|---|
|
|
|---|
seal, seal/input resistance, access resistance, and capacitance were measured in a voltage clamp every 10 sec for 530 min to monitor insertion of the pores and every few minutes throughout the recordings to check quality (Fig. 1
, and there was little change in membrane potential over 5-fold decrement in access resistance to an acceptable quality of 100 M
.
|
|
|
Expression of KCC-2, NKCC-1, and CLC-2 in GT17 Cells
The finding that GnRH neurons maintain an elevated intracellular chloride concentration led us to investigate which of the transporters and channels typically involved in chloride homeostasis are expressed in these cells. Initially these studies were performed in GT17 cells, an immortalized murine GnRH neuronal cell line that allows molecular analyses not possible on GnRH neurons in situ (26). GT17 cells do not express detectable levels of KCC-2 mRNA (Fig. 3A
) or protein (Fig. 3F
, left panels). Although GT17 cells contain both CLC-2 mRNA (Fig. 3B
) and a CLC-2 protein species of correct molecular size (Fig. 3D
), confocal microscopy revealed that this protein is not appropriately targeted to the cell membrane (Fig. 3F
, upper middle and right panels), assuming instead a perinuclear location that would preclude its participation in cytoplasmic chloride homeostasis. In contrast to KCC-2, GT17 cells showed readily detectable levels of NKCC-1 mRNA (Fig. 3C
), NKCC-1 protein species of the appropriate size (27) (Fig. 3E
), and cellular expression of the NKCC-1 protein (Fig. 3F
, lower middle and right panels). Thus, the depolarizing response of GT17 cells to GABAA receptor stimulation (8) appears to be related to both the absence of chloride cotransporter/channels able to extrude intracellular chloride, and the presence of a cotransporter that accumulates intracellular chloride against its electrochemical equilibrium.
|
|
2 analysis). In no instance were GnRH neurons containing CLC-2 mRNA detected (not shown). The vast majority of KCC-2- and NKCC-1-expressing GnRH neurons were in the anterior region of the preoptic area where the greatest concentration of neuroendocrine GnRH neurons is normally observed (Fig. 5
|
|
access resistance was attained. Although bumetanide has been reported to alter intracellular chloride in the absence of NKCC-1 (29), suggesting it can act on KCC family members as well, the hyperpolarization of EGABA observed in the present study is consistent with the primary effect of bumetanide being inhibition of NKCC-1. Together with the molecular and immunohistochemical studies presented above, these data suggest that a member of the NKCC family is expressed in GnRH neurons and actively maintains an elevated intracellular chloride concentration in these cells. Because EGABA was hyperpolarized in all bumetanide-treated GnRH neurons relative to untreated GnRH neurons, it appears that the expression of functional NKCC family members in GnRH neurons is more widespread than indicated by the in situ hybridization detection of NKCC-1 mRNA. This underestimation may be due to both a low prevalence of NKCC-1 mRNA per neuron and the stringent criteria used for identifying a cell as positive.
|
|
|
|
Long-Term Activation of the GABAA Receptor Inhibits GnRH Neurons
The present results showing that activation of the GABAA receptor excites GnRH neurons is in conflict with numerous studies that have approached this question in vivo or in hypothalamic explants using GABA or GABA agonists (reviewed in Refs. 1 and 2 ; also Refs. 34 and 35) and with the one published report examining GnRH neurons directly in brain slices (17). These studies examined the response of the hypothalamic-pituitary axis to prolonged exposure (
1 min) to GABA. We thus examined the effects of bath application of muscimol, a GABAA receptor agonist, on action currents in GnRH neurons recorded in on-cell mode. Muscimol (50 µM) had a biphasic effect on action current firing in GnRH neurons (Fig. 10
, A and B, n = 19 cells). An example from a cell that was quiescent is shown in Fig. 10A
(10 of 19 cells), whereas an example from a cell that was spontaneously active at the time of the study is shown in Fig. 10B
(9 of 19 cells, minimum of three spontaneous action currents). There was an increase in the rate of action current firing within approximately 60 sec from adding the muscimol to the perifusion system (there is a delay of
4560 sec to initiate solution exchange at the slice) regardless of whether the cell was quiescent or active. This excitation gave rise to inhibition within 1020 sec. During this muscimol-induced inhibition, the excitatory response to rapidly applied GABA was lost. Upon washout of muscimol, the lack of response to rapid GABA application persisted for 415 min (10.2 ± 0.9 min, n = 13 recordings of adequate duration to observe washout). At least four phenomena could contribute to this: collapse of the chloride gradient, desensitization of the GABAA receptor, depolarization of the cell toward EGABA, and shunting inhibition secondary to changes in input resistance. On-cell measurements of resting membrane potential and the response to rapid GABA application (as above) made before and after muscimol application (Fig. 10C
) demonstrated membrane potential was not different but the depolarizing response to GABA was eliminated (Table 3
). This indicates that inhibition of firing due to prolonged depolarization of the membrane potential cannot account for the muscimol effect. Measurement of GABA-evoked currents in whole-cell voltage clamp mode with 20 mM pipette chloride revealed the response to GABA persisted in muscimol but the amplitude of the currents was diminished (n = 3 cells). Furthermore, the chloride reversal hyperpolarized during muscimol application and input resistance was markedly reduced. These observations in whole-cell mode suggest that a combination of collapse of the chloride gradient, receptor desensitization, and shunting inhibition contribute to the inhibition of firing after strong activation of the GABAA receptor by muscimol. Future studies will distinguish between these possibilities.
|
|
| DISCUSSION |
|---|
|
|
|---|
These observations appear to contradict a body of work that largely suggests GABAA receptor activation inhibits GnRH neurons. In vivo, there is an inverse relationship between preoptic GABA levels and LH release in rodents and sheep (35, 36, 37), and hypothalamic application of GABAA antagonists (38, 39, 40) increased LH release. Furthermore, puberty in primates was advanced by administration of GABAA antagonists or blockade of GABA synthesizing enzymes (41) due to premature activation of GnRH neurons. Measurement of GnRH release from hypothalamic explants has given mixed results. In some studies, using tissue fragments that include the entire medial basal hypothalamus and the preoptic region, blockade of GABAA receptors was shown to increase GnRH release from immature hypothalami but decreased it from mature hypothalami (34). In others, activation of GABAA receptors from hypothalamic fragments comprising only the arcuate-median eminence region stimulated GnRH release (42). Because in vivo manipulation of the GABAA receptor system has been consistently shown to inhibit LH release (38, 39, 40), it would appear that activation of GABAA receptors may lead to both inhibition and stimulation of GnRH release, but that the latter response is masked when the entire neuronal circuitry controlling GnRH release is subjected to GABAA receptor-mediated activation. Additionally, gonadotropes express the GABAA receptor, so direct modulation of LH release by GABA may be possible (43). It then follows that the aforementioned multineuronal systems cannot be used to resolve the nature of direct effects on GnRH neurons mediated by GABAA receptors.
The present approach addresses this issue by directly analyzing the response of GnRH neurons to GABAA receptor stimulation using electrophysiological approaches. EGABA is an intrinsic property of neurons and thus determines the responsiveness of the GnRH neuron to activation of the GABAA receptor independent of other cell types. The observations in the present study that EGABA is depolarized in GnRH neurons and that brief local application of GABA excites these cells suggest that the inhibition of LH and GnRH release described in previous studies may be due to GABA modulating neurons afferent to GnRH neurons. Consistent with this, a temporally controlled, local increase in GABA availability near GnRH nerve terminals in the median eminence resulted in stimulation of the hypothalamic-pituitary-ovarian axis, instead of the expected inhibition (44).
Another important difference between our study and those using whole animals or tissue fragments is the method of GABA application, which was brief and near the GnRH neuron being recorded in the present study as opposed to long-term and widespread in most previous reports. Although even brief focal application of GABA may influence surrounding cells, the treated area is markedly smaller; furthermore, the inclusion of tetrodotoxin, APV, and CNQX would eliminate most neurotransmission. More importantly, this treatment is substantially more acute as illustrated by the rapid recovery of action currents in the control cell in Fig. 9A
(onset of inhibition about 10 msec post-GABA, recovery within
200 msec) and equally rapid cessation of GABA-induced action current firing in GnRH neurons (Fig. 9B
). Activation of GABAA receptors can change the intracellular chloride concentration (e.g. Ref. 45), diminishing response to subsequent activation of these receptors. In the present measures of EGABA, this pitfall was avoided by allowing sufficient time between brief GABA applications for recovery of the chloride gradient. This diminished response was evident when the GABAA agonist muscimol was bath applied to mimic previous studies in which the GABAA receptor was strongly activated over a prolonged time. Muscimol caused an initial increase in firing rate followed by a prolonged suppression. During muscimol and for several minutes after, brief GABA did not excite GnRH neurons. On-cell measures of membrane potential and whole-cell recordings indicated this lack of response to GABA had several components including collapse of the chloride gradient, partial desensitization of GABAA receptors, and shunting inhibition. The question remains: what is the physiological GABA input to GnRH neurons? It is clear that GnRH neurons experience brief synaptically mediated GABAA receptor currents (46, 47). It remains to be determined whether tonic GABA signals that have been reported in other brain regions (48) are part of the physiological repertoire of GABAs influence on GnRH neurons.
The present findings disagree with a recently published report in which a gramicidin-perforated patch was used to examine the response of GnRH neurons identified by 5-chlormethyl-fluorescein di-ß-D-galactopyranosidase cleavage in mouse brain slices from GnRH-ß-galactosidase transgenics (17). In that report, bath-applied GABA had different effects among immature, peripubertal, and adult mice, with GnRH neurons from adults typically hyperpolarized by GABA. The same mechanisms that underlie the inhibition of GnRH neurons in the presence of muscimol could explain the inhibition of adult GnRH neurons observed in that study. Another possibility is that the ß-galactosidase transgenic reveals a different subpopulation of GnRH neurons than GFP does; approximately 30% of GnRH neurons are revealed by the former and about 7090% by the latter. The molecular characterization of chloride cotransporters in the present study suggests that subpopulations of GnRH neurons may exist with regard to chloride homeostatic mechanisms, but also that a putatively chloride-extruding (i.e. KCC-2-expressing) subpopulation is quite small (
5% of cells). Although this percentage was estimated from a relatively small sample size, it is remarkably similar to that of GnRH neurons in which rapid GABA failed to elicit action currents. Whether or not such a subpopulation, which would be expected to have a very different response to GABA, has a separate physiological function is an interesting question for future studies.
Unlike the previous study (17), we found no shift in the response of GnRH neurons to activation of the GABAA receptor. Instead, GABA excited GnRH neurons from a variety of reproductive models and at different circadian times. Furthermore, there were no developmental changes in chloride cotransporter expression detected in GnRH neurons. KCC-2 was not only absent from GT17 cells, but also from a majority of mature GnRH neurons. Conversely, NKCC-1 was expressed in both the immature cells and mature neurons. Importantly, this differential expression was observed in both rats and mice, indicating that instead of being a peculiarity of GT17 cells, the difference is preserved in native neurons of two different rodent species, and thus it has a much broader physiological significance. Although the levels of NKCC-1 mRNA in adult GnRH neurons may not be sufficiently high to be detected by in situ hybridization in all neurons, the electrophysiological response of these cells to bumetanide, an inhibitor of Na-K-2Cl transport, was remarkably consistent, suggesting that NKCC-dependent responses to GABAA receptor activation are integral features of GnRH neuron physiology throughout development. This is different from many neuronal systems in which expression of chloride cotransporters is developmentally regulated. Specifically, in rat hippocampal and neocortical pyramidal cells and in the hypothalamus, NKCC-1 dominates in early postnatal life whereas KCC-2 expression is low during the first postnatal week but soon reaches mature levels (10). The early neonatal cotransporter milieu generates elevated intracellular chloride levels; the response to GABAA receptor activation in many immature neurons is thus depolarizing (e.g. Ref. 49). As KCC-2 expression increases during early postnatal life, neuronal chloride levels are reduced and the excitatory response dissipates in most systems (10, 11).
Based on this developmental change in other systems, we and others (17, 34) hypothesized that there would be a shift in chloride homeostasis and response to GABAA receptor activation in GnRH neurons at puberty and other reproductive transitions. The relative lack of KCC-2 expression and persistence of NKCC-1 expression in GnRH neurons, in combination with the elevated intracellular chloride levels and consistent excitatory response of these cells to GABA, forces us to reject this hypothesis. Shifts in response of GnRH neurons to activation of the GABAA receptor thus cannot explain changes in GnRH secretion between different reproductive states.
Our data from GnRH neurons in brain slices agree with earlier reports of GABA action on the GT1 GnRH cell lines (7, 8). Bath application of GABA elicited a biphasic response in GnRH release from GT11 cells, with an initial stimulation due to activation of GABAA receptors and a prolonged inhibition through GABAB receptors (7). Because GT1 cells are clonal, action through non-GnRH afferents cannot explain this response. Patch-clamp analysis of GT17 cells revealed excitation in response to GABA (8). One interpretation of this excitatory response is that GT1 cells were likely transformed early in development and thus may represent immature neurons with regard to chloride cotransporter milieu. Our observations in adult GnRH neurons, however, suggest that the response in GT1 cells is physiological and that GnRH neurons do not undergo the typical postnatal shift in cotransporter expression that characterizes neurons that are inhibited by GABAA receptor activation.
A depolarizing response to GABAA receptor activation has been described during development (49), after neural trauma (50), in Rohon-Beard cells of the spinal cord (51), and in many adult sensory systems including dorsal root ganglion cells (29), horizontal cells of the retina (52), and primary olfactory sensory neurons (53). The latter is of particular interest with regard to GnRH neurons as their embryonic origin is the olfactory placode (54). The response to GABA in many neural systems, including spinal cord cells (51), fast-spiking interneurons of the cortex and amygdala (55), and thalamus (56), has been traced to elevated intracellular chloride concentrations resulting from reduced KCC-2 or persistent NKCC-1 activity (29, 57). The present finding in GnRH neurons supports and extends these observations to centrally located neuroendocrine cell type, reemphasizing the importance of chloride homeostasis in regulating the response to activation of the GABAA receptor.
Even in cells in which GABAA receptor activation is depolarizing, the final response is rarely excitatory in contrast to what we have consistently observed in GnRH neurons. This begs the question of why GnRH neurons are different from other cell types. One attractive possibility is that this permits GnRH neurons a degree of autonomy in responding to GABAergic inputs. That is, the excitatory response to GABAA receptors can be balanced with inhibition through GABAB receptors within the GnRH neuron itself by shifts in GABA receptor subtype expression. In this regard, the work of Lagrange et al. (19) demonstrated that activation of the GABAB receptor on GnRH neurons in guinea pigs inhibits these cells though gating of a G protein-coupled inwardly rectified potassium current. Our preliminary results suggest GABAB receptors also inhibit GnRH neurons in the mouse (DeFazio, R. A., S. D. Sullivan, and S. M. Moenter, unpublished). A more speculative possibility is that an opposite response of the reproductive axis to a prevalent neurotransmitter such as GABA would be one mechanism for achieving regulation that is out of phase with other neuroendocrine systems such as those governing stress (58) and lactation (59), which must essentially be turned off for reproduction to proceed. Although resolution of this issue awaits further investigation, the data in the present study redefine the role of GABAergic inputs to GnRH neurons by demonstrating that the response of the majority of GnRH neurons to rapid activation of the GABAA receptor is excitatory.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Female Sprague Dawley rats (B & K Universal, Fremont, CA) were used for immunohistofluorescence and combined immunohistochemistry/in situ hybridization studies. They were housed under 14-h light, 10-h dark photoperiod (lights on at 0500 h) and temperature (2325 C) and were given free access to tap water and pelleted rodent chow. Transgenic GnRH-GFP mice (18) and wild-type mice of the same strain were also employed for combined immunohistochemistry/in situ hybridization experiments. All animals were used in accordance with the NIH guide for the Care and Use of Laboratory Animals, and the experimental protocols were approved by the Oregon National Regional Primate Research Center Institutional Research Animal Committee.
Brain Slice Preparation
All reagents were purchased from Sigma(St. Louis, MO). All solutions were bubbled with 95% O2/5% CO2 throughout the experiments and for at least 30 min before exposure to tissue. Brain slices were prepared through the preoptic area and hypothalamus as previously described (60). The brain was rapidly removed and placed in ice-cold sucrose saline solution containing (in millimolar concentration): 250 sucrose, 3.5 KCl, 26 NaHCO3, 10 glucose, 1.25 NaHPO4, 1.2 MgSO4, and 3.8 MgCl2. Coronal 200-µm brain slices were cut with a vibratome (Ted Pella, Inc., Redding, CA) and incubated for 15 min at room temperature in a solution of 50% sucrose-saline and 50% normal saline (NS). NS contained (in millimolar concentration): 125 NaCl, 3.5 KCl, 26 NaHCO3, 10 glucose, 1.25 NaHPO4, 1.2 MgSO4, and 2.5 CaCl2. Slices were then transferred to a solution of 100% NS at 30-32 C for at least 90 min before recording.
Recording Solutions and Data Acquisition
The bath solution for recording was 100% NS plus 20 µM APV and 10 µM CNQX to block ionotropic glutamatergic receptors. Tetrodotoxin (0.5 µM) was included except when action currents or action potentials were monitored, as detailed below. During recording, slices were continuously superfused at 5 ml/min with oxygenated bath solution kept at 32 C with an inline-heating unit (Warner Instruments, Hamden, CT). GFP-positive cells were visualized with a combination of infrared differential interference contrast and fluorescence microscopy. Recordings were made with an EPC-8 patch-clamp amplifier (HEKA, Lambrecht, Germany). The data acquisition system consisted of an ITC-18 acquisition interface (Instrutech, Port Washington, NY) and Pulse control software (Instrutech) running within Igor Pro (Wavemetrics, Lake Oswego, OR) on a Macintosh G4 (Apple, Cupertino, CA).
GABA Application
Local pressure application of GABA was accomplished as previously described (11). Patch pipettes were filled with a HEPES-buffered saline (containing in millimolar concentration: 150 NaCl; 10 HEPES; 10 glucose; 3.5 KCl; 2.5 CaCl2; 1.3 MgCl2, pH 7.2; with NaOH) similar to the extracellular solution with the addition of 1 mM GABA. The pressure pipette was placed adjacent to the soma or proximal process and a 5- to 7-msec pulse of 3-10 psi was delivered using a Picospritzer II (General Valve Corp., East Hanover, NJ). Pressure application of the HEPES-buffered solution alone had no effect.
Gramicidin-Perforated Patch Recordings
Gramicidin-perforated patch recordings were performed using a modification of previously described methods (16). Patch pipettes (2-5 M
) were first filled with 1.251.75 µl of filtered, gramicidin-free internal solution and then backfilled with freshly sonicated, unfiltered pipette solution containing 1050 µg/ml gramicidin D. Gramicidin stock solution was prepared every 13 h at 50 mg/ml in DMSO. The pipette solution consisted of (in millimolar concentration): K gluconate, 139; KCl, 1; HEPES, 10; EGTA, 5; CaCl2, 0.1; MgCl2, 4, pH 7.2; with NaOH; for high chloride, K gluconate was replaced with KCl). Recording pipettes containing either 140 mM or 1 mM chloride were used with similar results after liquid junction correction of 3 and 10 mV, respectively [JPCalc (61)]. All voltages reported are corrected.
Gramicidin-perforated patch recordings were monitored as detailed in Results (Fig. 1
). Current-clamp recordings were initiated when the access resistance fell below 200 M
. Recordings were made in I = 0, zero current mode to eliminate voltage offsets due to the high access resistance of perforated patch mode. Voltage clamp recordings were initiated when the access resistance fell below 100 M
(range 27100 M
). Rupture of perforated patch recordings to whole-cell mode was detected by an abrupt decrease in access resistance associated with a rapid hyperpolarization of the reversal potential when 1 mM chloride pipette solution was used (as in Fig. 2
) or a reversal near 0 mV with 140 mM pipette chloride.
Voltage steps every 1015 mV bracketing the reversal potential were used; GABA was delivered as described above 250 msec into the voltage step to allow the membrane current to stabilize (56). Voltage steps and accompanying GABA puffs were delivered at an interval of 30 sec; this prevented decrement in the GABA response due to changes in intracellular chloride. Baseline current was measured just before the GABA pulse; GABA-induced current was measured 100 msec after rapid GABA application. The step potential was series resistance corrected independently for each measurement based on the absolute current, the series resistance and Ohms law (Vcorrected = Vstep - Verror; Verror = I * Rseries). Because the currents are different for the baseline and the GABA response, the step potential is different after correction (56). The reversal potential was determined from the crossing of the current-voltage relationship of the baseline current and the GABA response using a custom-written computer program running under IGOR Pro and verified by eye for each reversal. Only reversals that were stable (<5-mV variation) for two or more measurements (510 min) were accepted for this study. Intracellular chloride was estimated from reversal potentials using the Nernst equation (EGABA = 60.15 log [Cl-]i/[Cl-]o) assuming 100% of current through the GABAA receptor was carried by Cl- and a chloride activity coefficient of 0.76.
On-Cell Measurement of Membrane Potential
During a recording in the on-cell configuration, the patch of membrane within the pipette is exposed to a potential difference equal to the membrane potential (Vcell) minus the pipette command potential (Vpatch = Vcell - Vpipette). Potassium channels within the pipette can be manipulated by varying the pipette potential and the reversal of current through these channels (EK) used to estimate membrane potential (25, 30). This method assumes that the concentration of potassium in the cell is similar to that in the pipette solution, resulting in a reversal potential for potassium (EK) near 0. After establishing the on-cell configuration in the presence of 0.5 µM tetrodotoxin, inactivation of potassium channels is removed by setting Vpipette to +100 mV for 60 msec (Vpatch
-150 mV, assuming -50 mV Vcell). Channels are then activated by ramping the pipette voltage from +100 mV to -150 mV (Vpatch
-150 to +200 mV) over 30 msec. During the voltage ramp, potassium channels are opened and result in an initial inward current followed by an outward current. Leak correction was applied by subtracting a linear fit of the current during the ramp before the activation of potassium currents. The ramp potential where the leak corrected current crosses 0 pA reflects the membrane potential of the cell. Accurate assessment of Vcell relies on knowing the concentration of intracellular potassium, estimated to be approximately 150 mM (62). Although the concentration of intracellular potassium in GnRH neurons has not yet been determined, a difference of 15 mM results in an offset of only 5 mV (30). Such an offset would not affect the relative difference in membrane potential due to GABA. To assess the effect of rapid GABA, we delivered a control ramp to estimate the resting membrane potential, applied GABA, and then immediately delivered another ramp to estimate the membrane potential response to GABA (total duration of voltage protocol including both ramps was 300 msec, see Fig. 8A
). As reported previously (25, 30), we found that the absolute potentials (Table 2
) were on average more hyperpolarized than measurements in whole-cell or gramicidin methods, possibly due to Donnan potentials that exist during the latter recording modalities (25).
On-Cell Action Currents
After formation of the G
seal using any of the internal solutions, large amplitude fast current spikes were detected in voltage clamp at 0 mV and the response to rapid GABA application was evaluated (e.g. Ref. 63).
Response to Muscimol
To test the effects of long-term activation of the GABAA receptor, the GABAA receptor agonist muscimol (50 µM) was bath applied for 12 min. Action currents and membrane potential in response to rapid GABA application were determined as detailed above in the on-cell mode. Whole-cell recordings with 20 mM pipette chloride were used to assess GABAA receptor desensitization and input resistance changes in response to muscimol. Cells were held at -68 mV and stepped to a variable potential of -53 mV, -38 mV, or -15 mV to estimate the reversal potential. This was followed by a step to -38 mV (near the empirical reversal potential for 20 mM pipette chloride) to assess changes in [Cl-]in.
RT-PCR Cloning and Sequencing
Total RNA was isolated from GT17 cells and mouse cerebral cortex using TriReagent (Molecular Research Center, Inc., Cincinnati, OH) according to the manufacturers instructions. Two hundred nanograms were reverse transcribed for 1 h at 37 C using Omniscript Reverse Transcriptase (QIAGEN, Valencia, CA) in a 20-µl volume. Two microliters of each reaction were then subjected to PCR amplification [95 C for 15 min followed by 30 cycles of denaturing at 94 C for 30 sec, annealing at 57 C (for KCC-2 and CLC-2) or 52 C (for NKCC-1) for 1 min, and extension at 72 C for 1 min, followed by a final extension at 72 C for 10 min, using HotStarTaq Polymerase (QIAGEN)].
A 720-bp cDNA fragment of the mouse CLC-2 gene was amplified using oligodeoxynucleotides corresponding to nucleotide (nt) 520540 (5'-primer) and 12201240 (3'-primer) in the mouse CLC-2 mRNA sequence (64). A 260-bp cDNA fragment of the mouse KCC-2 gene was amplified using primers corresponding to nt 31683188 (5'-primer) and 34073427 (3'-primer) in the mouse KCC-2 mRNA sequence (65). In the case of NKCC-1, a 321-bp cDNA fragment was amplified using oligodeoxynucleotides corresponding to nt 32513271 (5'-primer) and 35513571 (3'-primer) in the coding region of mouse NKCC-1 mRNA (66). PCR products were cloned into the vector pGEM-T (Promega Corp., Madison, WI) and their identities were verified by sequencing.
Ribonuclease (RNase) Protection Assay
The procedure used has been described in detail elsewhere (67). In brief, each RNA sample was separately hybridized to 500,000 cpm of gel-purified 32P-UTP-labeled CLC-2, KCC-2, or NKCC-1 cRNA probes, each in combination with 5000 cpm of a 32P-UTP-labeled cyclophilin cRNA probe to correct for procedural variability (67). The cRNA probes were generated by SP6 or T7 polymerase-directed transcription using as templates each of the chloride channel cDNAs previously PCR cloned from cellular RNA. The cyclophilin probe was transcribed from a 158-bp PCR-generated cDNA fragment corresponding to nt 264421 in mouse cyclophilin mRNA (68).
Western Blots
For protein extraction of GT17 cells, cell monolayers were washed with ice-cold PBS and lysed with 1 ml radioimmunoprecipitation assay (RIPA) buffer. Protein extraction from frozen rodent tissue was performed using the same extraction solution in a glass homogenizer. The lysates were centrifuged at 13,000 x g, at 4 C for 15 min, and the supernatants were frozen at -85 C until use. Protein concentrations were estimated using the Bio-Rad protein assay (Bio-Rad Laboratories, Inc., Hercules, CA). Size fractionation was achieved by SDS-PAGE, using 8% polyacrylamide gel for CLC-2 and 6% gel for NKCC-1. After electrophoresis, proteins were transferred for 2 h at 1 Amp to polyvinylidene membranes (Pierce Chemical Co., Rockford, IL). Membranes were blocked with 3% milk in 0.05%Tween 20/Tris buffered saline (TBS, pH 7.4) for 1 h and incubated with the first antibody overnight at 4 C. For CLC-2 detection we used a rabbit polyclonal anti-CLC-2 serum (1:300, Alomone Labs, Jerusalem, Israel). The specificity of this antiserum was determined by preadsorbing it with the CLC-2 peptide used as antigen (1 µg CLC-2 peptide per 2 µg antibody in 0.05%Tween 20/TBS) for 2 h at room temperature before final dilution.
NKCC-1 was detected with rabbit anti-NKCC-1 polyclonal antibodies (1:500, overnight, at 4 C, a generous gift form E. Delpire, Vanderbilt University Medical Center, Nashville, TN) (69). After extensive washing with 0.05% Tween 20/TBS, membranes were exposed to horseradish peroxidase-conjugated goat antirabbit IgG (1:40,000, Pierce Chemical Co.) for 1 h at room temperature. After three washes in 0.05% Tween 20/TBS, bound antibody was detected by enhanced chemiluminescence using the Super Signal Western Dura chemiluminescence substrate (Pierce Chemical Co.).
Immunohistofluorescence-Confocal Microscopy
GT17 GnRH neurons were seeded on coverslips precoated with poly-L-ornithine and cultured in DMEM containing 10% fetal bovine serum plus penicillin (100 U/ml) and streptomycin (100 µg/ml), as described previously (68). At approximately 60% confluence, cells were rinsed with PBS, fixed in Zambonis fixative for 30 min at room temperature, and kept at 4 C in PBS until processed for immunohistochemistry.
Rat brains were fixed by transcardiac perfusion of Zambonis fixative as described earlier (70). Immunohistochemical reactions were performed on either 14-µm cryostat sections obtained from frozen, 20% sucrose-cryoprotected, optimal cutting temperature-embedded tissue, or 40-µm floating vibratome sections obtained from brain tissue that had been stored at 4 C in PBS after fixation (70). GnRH was identified with monoclonal antibody 4H3 (71) in both GT17 cells and brain sections (1:2000, overnight at 4 C and 1:3000, 48 h at 4 C, respectively). The reaction was developed with Texas Red goat antimouse
-globulin (1:200, Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) as outlined elsewhere (70). Initial examination of different antibodies to CLC-2, KCC-2, and NKCC-1 showed that some antibodies worked better in GT17 cells than in brain sections, and vice versa. Therefore, in each instance we selected the most appropriate antibody for immunostaining. CLC-2 was identified in GT17 cells with rabbit polyclonal antibodies (1:500, 48 h, 4 C) (14) (a generous gift from Rod Smith, University of Colorado Health Sciences Center, Denver, CO). For brain sections, we used chicken polyclonal antibodies against rat CLC-2 (1:5000, 48 h, 4 C) (72) (kindly provided by C. Murray and P. L. Zeitlin, John Hopkins Medical Institutions, Baltimore, MD). KCC-2 and NKCC-1 were identified in GT17 cells with polyclonal rabbit antibodies (73, 74) (generously provided by J. Payne, University of California School of Medicine, Davis, CA; and E. Delpire, Vanderbilt University Medical Center, Nashville, TN) diluted 1:500. In brain sections, the KCC-2 antibody was used at 1:1000, and NKKC1 staining was performed using monoclonal antibody T4 (78) diluted to 1.5 µg/ml (a generous gift from C. Lytle, University of California, Riverside, CA).
All chloride channel and transporter immunoreactions in GT17 cells were developed with a fluorescein isothiocyanate-labeled goat antirabbit
-globulin (1:200, Jackson ImmunoResearch Laboratories, Inc.) (70). For brain sections, the reactions were developed using the biotinylated tyramine enhancement method, and the appropriate biotinylated secondary antibodies, as previously described (76). Cell nuclei were detected by staining with Hoechst 33258 (Molecular Probes, Inc., Eugene, OR) at 0.1 µg/ml potassium PBS for 1 min after completion of the immunohistochemical reactions (44). The immunofluorescence images were acquired with a TCS-SP laser scanning confocal system (Leica Corp., Heidelberg, Germany) and a Leica Corp.IRBE microscope, as previously described (44).
Combined Immunohistochemistry/in Situ Hybridization
These experiments were performed to determine the presence of CLC-2, KCC-2, and NKCC-1 mRNA in GnRH neurons during postnatal development of the rodent hypothalamus. The brains of infantile (3-d-old), prepubertal (28-d-old), and adult (60-d-old) female rats, as well as the brains of adult 50-d-old GnRH-GFP and wild-type mice were fixed by transcardiac perfusion with 4% paraformaldehyde in borate buffer, pH 9.5 (77), and subjected to combined immunohistochemistry/in situ hybridization, using procedures described in detail elsewhere (70). The reactions were performed on 14-µm cryostat sections and every other section analyzed (i.e. a periodicity of every 28 µm for each probe). GnRH neurons were identified with monoclonal antibody 4H3 (71), diluted at 1:1000. Upon completion of the immunohistochemical reaction, the sections were dried in a vacuum oven, and the next day CLC-2, KCC-2, and NKCC-1 mRNAs were detected using the same riboprobe used in RNA protection assays, but labeled with 35S-UTP instead of 32P-UTP. The hybridization mixture (71, 72) contained 5 x 107 cpm/ml of NICK column (Pharmacia Biotech)-purified labeled probe. The hybridization reaction was carried out for 20 h at 55 C; posthybridization washes in decreasing concentrations of sodium chloride-sodium citrate buffer (SSC) were as reported (71, 72) to a final stringency of 0.1 x sodium chloride-sodium citrate buffer at 65 C and were preceded by an RNase digestion step (30 min at 37C with 20 µl RNase/ml). Control sections were incubated with sense RNA probes transcribed from the same plasmids but linearized on their 3'-end to transcribe the coding strand of each cDNA. A more detailed description of the in situ hybridization procedure used can be found in Refs. 71 and 72 . After dehydration in graded alcohols, the slides were exposed to Hyperfilm (Amersham Biosciences, Piscataway, NJ) x-ray film for 3 d to verify the specificity and tissue pattern of hybridization; thereafter, the sections were defatted, and dipped in NTB-2 emulsion (Roche, Indianapolis, IN). The reaction was developed 3 wk later, and the sections were counterstained with 1% methyl green before analysis under both bright- and dark-field illumination. GnRH neurons were considered to express a cotransporter mRNA when they had 10 or more silver grains overlying the nucleus and perikaryon. In all cases, the density of silver grains overlying a positive cell was at least 3 times that of adjacent areas devoid of cells.
Statistics
Data are reported as mean ± SEM. Comparisons between GnRH and non-GnRH neurons were made by two-tailed t test with P < 0.05 accepted as significant. The
2 goodness of fit analysis was employed to determine the statistical significance of differences in the number of GnRH neurons containing NKCC-1 and KCC-2 mRNA.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
1 R.A.D. and S.H. contributed equally to these studies. ![]()
Abbreviations: APV, D-(-)-2-Amino-5-phosphonopentanoic acid; CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione; GABA,
-aminobutyric acid; GFP, green fluorescent protein; KCC, potassium-chloride contransporter; NKCC, sodium-potassium-2-chloride cotransporter; NS, normal saline; nt, nucleotide; OVX, ovariectomy; OVX+E, ovariectomy + estradiol; RNase, ribonuclease; TBS, Tris-buffered saline.
Received for publication May 2, 2002. Accepted for publication September 9, 2002.
| REFERENCES |
|---|
|
|
|---|
-aminobutyric and catecholamines in the preoptic/septal area prior to and during the preovulatory surge of luteinizing hormone in the ewe. J Neuroendocrinol 3:393399
-aminobutyric acid receptor antagonists into the medial preoptic and arcuate ventromedial region on luteinizing hormone release in male sheep. Biol Reprod 58:10381046
-aminobutyric acid modulation of ovarian hormonal effects on luteinizing hormone secretion and hypothalamic catecholamine activity in the female rat. Endocrinology 118:9197
aminobutyric acid and the pubertal increase in luteinizing hormone releasing hormone release in the female rhesus monkeys. J Neuroendocrinol 11:275282[CrossRef][Medline]
-Aminobutyric acid (GABA): a para- and/or autocrine hormone in the pituitary. FASEB J 15:10891091
amino butyric acid production near luteinizing hormone-releasing hormone nerve terminals disrupts estrous cyclicity in the rat. Endocrinology 142:21022114
, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neurons. J Clin Endocrinol Metab 84:46954701This article has been cited by other articles:
![]() |
M. Matsuda, K. Tsutsumi, T. Kanematsu, K. Fukami, Y. Terada, T. Takenawa, K. I. Nakayama, and M. Hirata Involvement of Phospholipase C-Related Inactive Protein in the Mouse Reproductive System Through the Regulation of Gonadotropin Levels Biol Reprod, October 1, 2009; 81(4): 681 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kim and L. O. Trussell Negative Shift in the Glycine Reversal Potential Mediated by a Ca2+- and pH-Dependent Mechanism in Interneurons J. Neurosci., September 16, 2009; 29(37): 11495 - 11510. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chen and S. M. Moenter GABAergic Transmission to Gonadotropin-Releasing Hormone (GnRH) Neurons Is Regulated by GnRH in a Concentration-Dependent Manner Engaging Multiple Signaling Pathways J. Neurosci., August 5, 2009; 29(31): 9809 - 9818. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watanabe, Y. Sakuma, and M. Kato GABAA Receptors Mediate Excitation in Adult Rat GnRH Neurons Biol Reprod, August 1, 2009; 81(2): 327 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Christian, J. Pielecka-Fortuna, and S. M. Moenter Estradiol Suppresses Glutamatergic Transmission to Gonadotropin-Releasing Hormone Neurons in a Model of Negative Feedback in Mice Biol Reprod, June 1, 2009; 80(6): 1128 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zhang, M. A. Bosch, O. K. Ronnekleiv, and M. J. Kelly {gamma}-Aminobutyric Acid B Receptor Mediated Inhibition of Gonadotropin-Releasing Hormone Neurons Is Suppressed by Kisspeptin-G Protein-Coupled Receptor 54 Signaling Endocrinology, May 1, 2009; 150(5): 2388 - 2394. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chu, J. Andrade, M. A. Shupnik, and S. M. Moenter Differential Regulation of Gonadotropin-Releasing Hormone Neuron Activity and Membrane Properties by Acutely Applied Estradiol: Dependence on Dose and Estrogen Receptor Subtype J. Neurosci., April 29, 2009; 29(17): 5616 - 5627. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Constantin, C. S. Caligioni, S. Stojilkovic, and S. Wray Kisspeptin-10 Facilitates a Plasma Membrane-Driven Calcium Oscillator in Gonadotropin-Releasing Hormone-1 Neurons Endocrinology, March 1, 2009; 150(3): 1400 - 1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Choi, C. M. Ha, E. J. Choi, C. S. Jeong, J. W. Park, J.-H. Baik, J.-Y. Park, M. E. Costa, S. R. Ojeda, and B. J. Lee Kinesin Superfamily-Associated Protein 3 Is Preferentially Expressed in Glutamatergic Neurons and Contributes to the Excitatory Control of Female Puberty Endocrinology, December 1, 2008; 149(12): 6146 - 6156. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Roberts and K. J. Suter Emerging methodologies for the study of hypothalamic gonadotropin-releasing-hormone (GnRH) neurons Integr. Comp. Biol., November 1, 2008; 48(5): 548 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Christian and S. M. Moenter Critical Roles for Fast Synaptic Transmission in Mediating Estradiol Negative and Positive Feedback in the Neural Control of Ovulation Endocrinology, November 1, 2008; 149(11): 5500 - 5508. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Christian, C. Glidewell-Kenney, J. L. Jameson, and S. M. Moenter Classical Estrogen Receptor {alpha} Signaling Mediates Negative and Positive Feedback on Gonadotropin-Releasing Hormone Neuron Firing Endocrinology, November 1, 2008; 149(11): 5328 - 5334. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Christian and S. M. Moenter Vasoactive Intestinal Polypeptide Can Excite Gonadotropin-Releasing Hormone Neurons in a Manner Dependent on Estradiol and Gated by Time of Day Endocrinology, June 1, 2008; 149(6): 3130 - 3136. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Bogusz, S. L. Hardy, M. N. Lehman, J. M. Connors, S. M. Hileman, J. H. Sliwowska, H. J. Billings, C. J. McManus, M. Valent, S. R. Singh, et al. Evidence that {gamma}-Aminobutyric Acid Is Part of the Neural Circuit Mediating Estradiol Negative Feedback in Anestrous Ewes Endocrinology, June 1, 2008; 149(6): 2762 - 2772. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Hill, J. K. Elmquist, and C. F. Elias Hypothalamic pathways linking energy balance and reproduction Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E827 - E832. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Christian and S. M. Moenter Estradiol Induces Diurnal Shifts in GABA Transmission to Gonadotropin-Releasing Hormone Neurons to Provide a Neural Signal for Ovulation J. Neurosci., February 21, 2007; 27(8): 1913 - 1921. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Cottrell, R. E. Campbell, S.-K. Han, and A. E. Herbison Postnatal Remodeling of Dendritic Structure and Spine Density in Gonadotropin-Releasing Hormone Neurons Endocrinology, August 1, 2006; 147(8): 3652 - 3661. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.K. Blank, C.R. McCartney, and J.C. Marshall The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome Hum. Reprod. Update, July 1, 2006; 12(4): 351 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. El-Etr, Y. Akwa, E.-E. Baulieu, and M. Schumacher The Neuroactive Steroid Pregnenolone Sulfate Stimulates the Release of Gonadotropin-Releasing Hormone from GT1-7 Hypothalamic Neurons, through N-Methyl-D-Aspartate Receptors Endocrinology, June 1, 2006; 147(6): 2737 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pielecka and S. M. Moenter Effect of Steroid Milieu on Gonadotropin-Releasing Hormone-1 Neuron Firing Pattern and Luteinizing Hormone Levels in Male Mice Biol Reprod, May 1, 2006; 74(5): 931 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pielecka, S. D. Quaynor, and S. M. Moenter Androgens Increase Gonadotropin-Releasing Hormone Neuron Firing Activity in Females and Interfere with Progesterone Negative Feedback Endocrinology, March 1, 2006; 147(3): 1474 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Ojeda, A. Lomniczi, C. Mastronardi, S. Heger, C. Roth, A.-S. Parent, V. Matagne, and A. E. Mungenast Minireview: The Neuroendocrine Regulation of Puberty: Is the Time Ripe for a Systems Biology Approach? Endocrinology, March 1, 2006; 147(3): 1166 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Roberts, J. A. Best, and K. J. Suter Dendritic Processing of Excitatory Synaptic Input in Hypothalamic Gonadotropin Releasing-Hormone Neurons Endocrinology, March 1, 2006; 147(3): 1545 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lomniczi, A. Cornea, M. E. Costa, and S. R. Ojeda Hypothalamic Tumor Necrosis Factor-{alpha} Converting Enzyme Mediates Excitatory Amino Acid-Dependent Neuron-to-Glia Signaling in the Neuroendocrine Brain J. Neurosci., January 4, 2006; 26(1): 51 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Moenter and R. A. DeFazio Endogenous {gamma}-Aminobutyric Acid Can Excite Gonadotropin-Releasing Hormone Neurons Endocrinology, December 1, 2005; 146(12): 5374 - 5379. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chu and S. M. Moenter Endogenous Activation of Metabotropic Glutamate Receptors Modulates GABAergic Transmission to Gonadotropin-Releasing Hormone Neurons and Alters Their Firing Rate: A Possible Local Feedback Circuit J. Neurosci., June 15, 2005; 25(24): 5740 - 5749. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Mitchell, X. F. Li, L. Breen, J.-C. Thalabard, and K. T. O'Byrne The Role of the Locus Coeruleus in Corticotropin-Releasing Hormone and Stress-Induced Suppression of Pulsatile Luteinizing Hormone Secretion in the Female Rat Endocrinology, January 1, 2005; 146(1): 323 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Sullivan and S. M. Moenter GABAergic Integration of Progesterone and Androgen Feedback to Gonadotropin-Releasing Hormone Neurons Biol Reprod, January 1, 2005; 72(1): 33 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-S. Parent, M.-C. Lebrethon, A. Gerard, and J.-P. Bourguignon Factors Accounting for Perinatal Occurrence of Pulsatile Gonadotropin-Releasing Hormone Secretion In Vitro in Rats Biol Reprod, January 1, 2005; 72(1): 143 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Ottem, J. G. Godwin, S. Krishnan, and S. L. Petersen Dual-Phenotype GABA/Glutamate Neurons in Adult Preoptic Area: Sexual Dimorphism and Function J. Neurosci., September 15, 2004; 24(37): 8097 - 8105. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Sullivan and S. M. Moenter Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: Implications for a common fertility disorder PNAS, May 4, 2004; 101(18): 7129 - 7134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Sullivan and S. M. Moenter {gamma}-Aminobutyric Acid Neurons Integrate and Rapidly Transmit Permissive and Inhibitory Metabolic Cues to Gonadotropin-Releasing Hormone Neurons Endocrinology, March 1, 2004; 145(3): 1194 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Xu, X.-Z. Xu, C. S. Nunemaker, and S. M. Moenter Dose-Dependent Switch in Response of Gonadotropin-Releasing Hormone (GnRH) Neurons to GnRH Mediated through the Type I GnRH Receptor Endocrinology, February 1, 2004; 145(2): 728 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Han, M. G. Todman, and A. E. Herbison Endogenous GABA Release Inhibits the Firing of Adult Gonadotropin-Releasing Hormone Neurons Endocrinology, February 1, 2004; 145(2): 495 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Jackson and D. Kuehl Effects of Applying Gamma-Aminobutyric AcidB Drugs into the Medial Basal Hypothalamus on Basal Luteinizing Hormone Concentrations and on Luteinizing Hormone Surges in the Female Sheep Biol Reprod, February 1, 2004; 70(2): 334 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Plant and M. L. Barker-Gibb Neurobiological mechanisms of puberty in higher primates Hum. Reprod. Update, January 1, 2004; 10(1): 67 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Sullivan and S. M. Moenter Neurosteroids Alter {gamma}-Aminobutyric Acid Postsynaptic Currents in Gonadotropin-Releasing Hormone Neurons: A Possible Mechanism for Direct Steroidal Control Endocrinology, October 1, 2003; 144(10): 4366 - 4375. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Sullivan, R. A. DeFazio, and S. M. Moenter Metabolic Regulation of Fertility through Presynaptic and Postsynaptic Signaling to Gonadotropin-Releasing Hormone Neurons J. Neurosci., September 17, 2003; 23(24): 8578 - 8585. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Jansen, C. Cutter, S. Hardy, M. N. Lehman, and R. L. Goodman Seasonal Plasticity within the Gonadotropin-Releasing Hormone (GnRH) System of the Ewe: Changes in Identified GnRH Inputs and Glial Association Endocrinology, August 1, 2003; 144(8): 3663 - 3676. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Leupen, S. A. Tobet, W. F. Crowley Jr., and K. Kaila Heterogeneous Expression of the Potassium-Chloride Cotransporter KCC2 in Gonadotropin-Releasing Hormone Neurons of the Adult Mouse Endocrinology, July 1, 2003; 144(7): 3031 - 3036. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Heger, M. Seney, E. Bless, G. A. Schwarting, M. Bilger, A. Mungenast, S. R. Ojeda, and S. A. Tobet Overexpression of Glutamic Acid Decarboxylase-67 (GAD-67) in Gonadotropin-Releasing Hormone Neurons Disrupts Migratory Fate and Female Reproductive Function in Mice Endocrinology, June 1, 2003; 144(6): 2566 - 2579. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |